Brief: 60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract
18/03/2026 12:06
March 18 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O: 60 DEGREES PHARMACEUTICALS FILES NEW DIETARY INGREDIENT NOTIFICATION (NDIN) WITH FDA FOR AUSTRALIAN CHESTNUT EXTRACT 60 DEGREES PHARMACEUTICALS INC - FDA HAS UNTIL MAY 25, 2026 TO OBJECT TO NDIN FOR AUSTRALIAN CHESTNUT EXTRACT Source text: ID:nGNX8XF4qH Further company coverage: SXTP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on 60 Degrees Pharmaceuticals
See all newsBrief: 60 Degrees Pharmaceuticals Says May Submit NDA For Tafenoquine To FDA Before End Of Q1 2028 - SEC Filing
U.S. RESEARCH ROUNDUP-Analog Devices, Intuit, NVIDIA
Brief: 60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract
NASDAQ RESUMED AT 10:06 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM